Abilify, Seroquel, Clozaril--Warning: Incr risk of hyperglycemia

[Guest guest]

Colleagues, the following is FYI; I have no further knowledge of the topic.

------------------------

Abilify (aripiprazole)

Audience: Neuropsychiatric healthcare professionals

FDA and Bristol-Myers Squibb notified healthcare professionals of

revision to the WARNINGS section of labeling, describing the risk of

hyperglycemia and diabetes in patients taking Abilify. FDA asked all

manufacturers of atypical antipsychotic medications, including

Bristol-Myers Squibb, to add this Warning statement to labeling.

[March 25, 2004 Letter - FDA]

Seroquel (quetiapine fumarate)

Audience: Neuropsychiatric healthcare professionals

FDA and AstraZeneca notified healthcare professionals of revision

to the WARNINGS section of labeling, describing the increased risk of

hyperglycemia and diabetes in patients taking Seroquel. FDA has asked

all manufacturers of atypical antipsychotic medications, including

AstraZeneca, to add this Warning statement to labeling.

[January 30, 2004 Letter - AstraZeneca LP]

Clozaril (clozapine)

Audience: Neuropsychiatric healthcare professionals

FDA and Novartis notified healthcare professionals of revision to

the WARNINGS section of labeling, describing the increased risk of

hyperglycemia and diabetes in patients taking Clozaril. FDA has asked

all manufacturers of atypical antipsychotic medications, including

Novartis, to add this Warning statement to labeling.

http://www.fda.gov/medwatch/SAFETY/2004/safety04.htm#chronological

--

ne Holden, MS, RD < fivestar@... >

" Ask the Parkinson Dietitian " http://www.parkinson.org/

" Eat well, stay well with Parkinson's disease "

" Parkinson's disease: Guidelines for Medical Nutrition Therapy "

http://www.nutritionucanlivewith.com/